Article Information
History
- July 14, 2022.
Article Versions
- Version 1 (February 15, 2022 - 17:54).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Alok Choudhary, PhD1,*,
- Mark Lerman, MD2,
- David Calianese, PhD1,
- Salman Khan, MD2,
- Judson Hunt, MD2,
- Afzal Nikaein, PhD3,
- Avi Z. Rosenberg, MD4,
- Jonathan I. Silverberg, MD5,
- Israel Zyskind, MD6,
- William Honnen, BS1,
- Dabbu K. Jaijyan, PhD1,
- Erica Kalu, BS2 and
- Abraham Pinter, PhD1,*
- 1Rutgers University, PHRI, NJMS, Newark, NJ, USA
- 2Medical City Dallas Hospital, Dallas, TX, USA
- 3Texas Medical Specialty, Dallas, TX, USA
- 4Department of Pathology, Johns Hopkins University, Baltimore, Md
- 5George Washington University, Washington, DC
- 6Department of Pediatrics, NYU Langone Medical Center, New York, NY
- ↵*CORRESPONDENCE INFORMATION:
Alok Choudhary, Public Health Research Institute, Rutgers University, 225 Warren Street, Newark, NJ, 07103, Email: choudhak{at}njms.rutgers.edu and Abraham Pinter, Public Health Research Institute, Rutgers University, 225 Warren Street, Newark, NJ, 07103, Email: pinterab{at}njms.rutgers.edu
Posted July 14, 2022.
Vaccination of solid organ transplant recipients previously infected with SARS-CoV2 induces potent responses that extend to variants, including Omicron
